Results 251 to 260 of about 59,126 (309)

Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Zaheen M, Ferdous F, Amarasekera AT, Petutschnigg J, Edelmann F, Tan TC.   +5 more
europepmc   +1 more source

Artificial intelligence‐based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Artificial intelligence (AI)‐based estimation of stroke volume for risk prediction in amyloid transthyretin cardiomyopathy (ATTR‐CM). ATTRv, hereditary transthyretin amyloidosis; ATTRwt, wild‐type transthyretin amyloidosis; CI, confidence interval; HR, hazard ratio; IQR, interquartile range; LVOT‐VTI, left ventricular outflow tract velocity‐time ...
Lucia Venneri, Alberto Aimo, Aldostefano Porcari, Irem Sezer, Adam Ioannou, Awais Sheikh, Josephine Mansell, Yousuf Razvi, Surabhi Bhaskar Iyer, Ana Martinez‐Naharro, Francesco Bandera, Sze Chi Lim, Matthew Frost, Justin Ezekowitz, Carolyn S.P. Lam, William Moody, Carol Whelan, Helen Lachmann, Ashutosh Wechelakar, Michele Emdin, Philip N. Hawkins, Scott David Solomon, Julian D. Gillmore, Marianna Fontana   +23 more
wiley   +1 more source

Unsupervised machine learning for cardiovascular disease: A framework for future studies

European Journal of Heart Failure, EarlyView.
Unsupervised machine learning can improve the characterization and stratification of patients with cardiovascular diseases (CVDs). Clustering algorithms, which group patients based on patterns in clinical data, can reveal distinct subgroups that may differ in prognosis and treatment response.
Emmanuel Bresso, Claire Lacomblez, Kévin Duarte, Luca Monzo, Guillaume Baudry, Jasper Tromp, Abhinav Sharma, Nicolas Girerd   +7 more
wiley   +1 more source

Role of 11β-Hydroxysteroid Dehydrogenase and Mineralocorticoid Receptor on Alzheimer's Disease Onset: A Systematic Review. [PDF]

Int J Mol Sci
Di Vincenzo M, Pellegrino P, Schiappa G, Campanati A, Del Vescovo V, Piccirillo S, Ambrogini P, Arnaldi G, Orciani M.   +8 more
europepmc   +1 more source

#3802 Real-world outcomes of switching from steroidal mineralocorticoid receptor antagonists (sMRA) to finerenone in patients with chronic kidney disease and type 2 diabetes (T2DM): a multicenter study in madrid community [PDF]

Beatriz Fernandez, Adriana Puente García, Alejandro Avello, David Arroyo Rueda, Maria De San Miguel Marques Vidas, Clara García Carro, Alberto Ortíz   +6 more
openalex   +1 more source

Short‐ and mid‐term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

European Journal of Heart Failure, EarlyView.
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi, Dennis Kannenkeril, Julie Kolwelter, Peter Linz, Agnes Bosch, Kristina Striepe, Marina V. Karg, Armin M. Nagel, Michael Uder, Mario Schiffer, Stephan Achenbach, Roland E. Schmieder   +11 more
wiley   +1 more source

Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease. [PDF]

Int J Mol Sci
de la Puente-Aldea J, Lopez-Llanos O, Horrillo D, Marcos-Sanchez H, Sanz-Ballesteros S, Franco R, Jaisser F, Senovilla L, Palacios-Ramirez R.   +8 more
europepmc   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus   +14 more
wiley   +1 more source

Mineralocorticoid receptor antagonism attenuates arteriovenous fistula stenosis by modulating the phenotype of vascular smooth muscle cells. [PDF]

Nephrol Dial Transplant
Liu Y, Chen B, Chen K, Wang Y, Zhou C, Liang X, Wang K, Wang P.   +7 more
europepmc   +1 more source